NM_003361.4(UMOD):c.743G>C (p.Cys248Ser) AND Familial juvenile hyperuricemic nephropathy type 1
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- May 15, 2010
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002251329.9
Allele description [Variation Report for NM_003361.4(UMOD):c.743G>C (p.Cys248Ser)]
NM_003361.4(UMOD):c.743G>C (p.Cys248Ser)
Condition(s)
- Name:
- Familial juvenile hyperuricemic nephropathy type 1 (ADTKD1)
- Synonyms:
- Medullary cystic kidney disease 2, autosomal dominant; TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 1; Glomerulocystic kidney disease with hyperuricemia and isosthenuria; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0008073; MedGen: C4551496; Orphanet: 209886; Orphanet: 34149; OMIM: 162000
-
DNA-binding transcriptional activator OsmE [Pseudomonas putida F1]
DNA-binding transcriptional activator OsmE [Pseudomonas putida F1]gi|148549935|ref|YP_001270037.1|Protein
-
Homo sapiens nerve growth factor receptor (NGFR), mRNA
Homo sapiens nerve growth factor receptor (NGFR), mRNAgi|1519246080|ref|NM_002507.4|Nucleotide
-
RecName: Full=U3 small nucleolar RNA-associated protein 25; Short=U3 snoRNA-asso...
RecName: Full=U3 small nucleolar RNA-associated protein 25; Short=U3 snoRNA-associated protein 25; AltName: Full=U three protein 25gi|332321782|sp|C5G0N1.1|UTP25_ARTOProtein
-
PREDICTED: Homo sapiens F-box and WD repeat domain containing 8 (FBXW8), transcr...
PREDICTED: Homo sapiens F-box and WD repeat domain containing 8 (FBXW8), transcript variant X6, misc_RNAgi|2462531289|ref|XR_008488563.1|Nucleotide
-
ATP synthase epsilon chain, partial (chloroplast) [Scrophularia arguta]
ATP synthase epsilon chain, partial (chloroplast) [Scrophularia arguta]gi|22797495|emb|CAD22408.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 10, 2024